Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | MET | P08581 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | MMP1 | P03956 | 1/20 | 0.44 |
| ▸ | MMP9 | P14780 | 1/20 | 0.44 |
| ▸ | MMP13 | P45452 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27012162 | 1.00 | MEN1 (0.57) | MEN1HTTKMT2AALDH1A1LMNA | |
| SCHEMBL29570638 | 0.94 | MET (0.52) | MEN1HTTKMT2AALDH1A1LMNA | |
| SCHEMBL27006653 | 0.86 | MEN1 (0.64) | MEN1HTTKMT2AALDH1A1LMNA | |
| SCHEMBL27006651 | 0.85 | ALDH1A1 (0.70) | MEN1HTTKMT2AALDH1A1LMNA | |
| SCHEMBL14990419 | 0.84 | ROCK2 (0.50) | MEN1HTTKMT2AALDH1A1LMNA | |
| SCHEMBL14990420 | 0.84 | ROCK2 (0.50) | MEN1HTTKMT2AALDH1A1LMNA | |
| SCHEMBL18229990 | 0.82 | PKM (0.62) | MEN1KMT2AALDH1A1LMNAMAPT | |
| SCHEMBL23779410 | 0.82 | KMT2A (0.52) | MEN1HTTKMT2AALDH1A1LMNA | |
| SCHEMBL23779411 | 0.82 | KMT2A (0.52) | MEN1HTTKMT2AALDH1A1LMNA | |
| SCHEMBL25170958 | 0.82 | PKM (0.53) | MEN1HTTKMT2AALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4225447-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Vertex Pharmaceuticals Incorporated (US) | 2023-08-16 | — | — | EP | disclosed |
| WO-2022076625-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |